Bayer -- the German multinational pharmaceutical and life sciences company -- recently expanded its portfolio with the launch of the new Astepro® Allergy nasal spray. The new steroid-free antihistamine nasal spray is designed to offer allergy relief. The new product is available as an over-the-counter product that will temporarily relieve nasal congestion, runny noses, sneezing, and itchy noses that are caused by hay fever or other upper respiratory allergies.
"At Bayer, we help make self-care a reality for billions through everyday healthcare. This new differentiated product is one step in that direction, with the potential to help millions of people in the U.S. that suffer from seasonal allergic rhinitis,” said Catherine Vennat, VP/GM Bayer Consumer Health U.S.
Image Credit: Shutterstock
Key Themes Behind This Trend
- Steroid-free Antihistamine Nasal Sprays
- Providing allergy relief while avoiding the use of steroids presents opportunities to innovate in the field of antihistamine medication.
- Over-the-counter Allergy Relief Products
- Investments in the development of new formulations of over-the-counter allergy relief products have the potential to cater to millions of people in the U.S. alone.
- Natural Antihistamine Treatment
- The search for a natural antihistamine treatment could lead to innovation in the health and wellness industry.
Where This Applies
- Pharmaceuticals
- Steroid-free antihistamine nasal sprays present opportunities for pharmaceutical companies to invest in new drug development.
- Consumer Health
- Bayer's introduction of Astepro Allergy Nasal Spray highlights the potential for innovation in the emerging market of over-the-counter allergy relief products.
- Health and Wellness
- Exploring natural antihistamine treatments presents new opportunities for health and wellness companies to introduce innovative products to the market.
